Relevance of HBV/HBcAb screening in lymphoma patients treated in the Rituximab era. [electronic resource]
Producer: 20100607Description: 342-4; author reply 345-6 p. digitalISSN:- 1865-3774
- Adult
- Aged
- Aged, 80 and over
- Antibodies, Monoclonal -- adverse effects
- Antibodies, Monoclonal, Murine-Derived
- Antineoplastic Agents -- adverse effects
- Female
- Hepatitis B -- diagnosis
- Hepatitis B Antibodies -- blood
- Hepatitis B Core Antigens -- immunology
- Humans
- Immunocompromised Host
- Lymphoma -- complications
- Male
- Middle Aged
- Rituximab
- Seroepidemiologic Studies
No physical items for this record
Publication Type: Comment; Letter
There are no comments on this title.
Log in to your account to post a comment.